Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID Q07954 4035 LRP1 A2MR APR Bladder urothelial carcinoma Ubiquitination N K336 Q07954 4035 LRP1 A2MR APR Hepatocellular carcinoma Ubiquitination N K336 Q07954 4035 LRP1 A2MR APR Skin cutaneous melanoma Ubiquitination N K336 Q07954 4035 LRP1 A2MR APR Colon adenocarcinoma N-linked glycosylation N N446 Q07954 4035 LRP1 A2MR APR Bladder urothelial carcinoma Methylation N K458 Q07954 4035 LRP1 A2MR APR Rectum adenocarcinoma Methylation N K458 Q07954 4035 LRP1 A2MR APR Bladder urothelial carcinoma Phosphorylation N S511 Q07954 4035 LRP1 A2MR APR Head and neck squamous cell carcinoma Phosphorylation N S511 Q07954 4035 LRP1 A2MR APR Skin cutaneous melanoma Phosphorylation N S511 Q07954 4035 LRP1 A2MR APR Skin cutaneous melanoma N-linked glycosylation N N729 Q07954 4035 LRP1 A2MR APR Stomach adenocarcinoma O-linked glycosylation N T1101 Q07954 4035 LRP1 A2MR APR Stomach adenocarcinoma Phosphorylation N S1417 Q07954 4035 LRP1 A2MR APR Uterine corpus endometrial carcinoma Phosphorylation N S1417 Q07954 4035 LRP1 A2MR APR Ovarian cancer Phosphorylation N S1419 Q07954 4035 LRP1 A2MR APR Stomach adenocarcinoma Phosphorylation N S1419 Q07954 4035 LRP1 A2MR APR Uterine corpus endometrial carcinoma Phosphorylation N S1419 Q07954 4035 LRP1 A2MR APR Pancreatic adenocarcinoma N-linked glycosylation N N1511 Q07954 4035 LRP1 A2MR APR Pancreatic adenocarcinoma Phosphorylation N T1513 Q07954 4035 LRP1 A2MR APR Lung adenocarcinoma N-linked glycosylation N N1575 Q07954 4035 LRP1 A2MR APR Uterine corpus endometrial carcinoma N-linked glycosylation N N1575 Q07954 4035 LRP1 A2MR APR Uterine corpus endometrial carcinoma N-linked glycosylation N N1616 Q07954 4035 LRP1 A2MR APR Hepatocellular carcinoma Phosphorylation N T1790 Q07954 4035 LRP1 A2MR APR Lung adenocarcinoma Phosphorylation N S2559 Q07954 4035 LRP1 A2MR APR Lung adenocarcinoma Phosphorylation N Y2560 Q07954 4035 LRP1 A2MR APR Lung adenocarcinoma Methylation N R2577 Q07954 4035 LRP1 A2MR APR Prostate adenocarcinoma Methylation N R2577 Q07954 4035 LRP1 A2MR APR Hepatocellular carcinoma O-linked glycosylation N T2773 Q07954 4035 LRP1 A2MR APR Skin cutaneous melanoma O-linked glycosylation N T2773 Q07954 4035 LRP1 A2MR APR Sarcoma N-linked glycosylation N N2815 Q07954 4035 LRP1 A2MR APR Uterine carcinosarcoma N-linked glycosylation N N2815 Q07954 4035 LRP1 A2MR APR Colon adenocarcinoma O-linked glycosylation N T2857 Q07954 4035 LRP1 A2MR APR Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S3217 Q07954 4035 LRP1 A2MR APR Pancreatic adenocarcinoma Phosphorylation N T3261 Q07954 4035 LRP1 A2MR APR Lung adenocarcinoma N-linked glycosylation N N3488 Q07954 4035 LRP1 A2MR APR Lung squamous cell carcinoma Methylation N R3500 Q07954 4035 LRP1 A2MR APR Uterine corpus endometrial carcinoma Methylation N R3500 Q07954 4035 LRP1 A2MR APR Skin cutaneous melanoma N-linked glycosylation N N3788 Q07954 4035 LRP1 A2MR APR Glioblastoma multiforme N-linked glycosylation N N3953 Q07954 4035 LRP1 A2MR APR Head and neck squamous cell carcinoma N-linked glycosylation N N3953 Q07954 4035 LRP1 A2MR APR Lung squamous cell carcinoma N-linked glycosylation N N3953 Q07954 4035 LRP1 A2MR APR Ovarian serous cystadenocarcinoma N-linked glycosylation N N3953 Q07954 4035 LRP1 A2MR APR Head and neck squamous cell carcinoma Phosphorylation N S4071 Q07954 4035 LRP1 A2MR APR Uterine corpus endometrial carcinoma N-linked glycosylation N N4125 Q07954 4035 LRP1 A2MR APR Bladder urothelial carcinoma Phosphorylation N S4249 Q07954 4035 LRP1 A2MR APR Skin cutaneous melanoma Phosphorylation N S4249 Q07954 4035 LRP1 A2MR APR Tricuspid atresia Phosphorylation N S4517 Q07954 4035 LRP1 A2MR APR Tricuspid atresia Phosphorylation N S4520 Q07954 4035 LRP1 A2MR APR Blastoma Phosphorylation N S4523 Q07954 4035 LRP1 A2MR APR Liver cancer Phosphorylation N S4523 Q07954 4035 LRP1 A2MR APR Tricuspid atresia Phosphorylation N S4523 Q07954 4035 LRP1 A2MR APR Tricuspid atresia Ubiquitination N K4527